Speaker illustration

Doctor Wilfried Dinh

Bayer Pharmaa AG, Wuppertal (Germany)

Member of:

European Society of Cardiology

A novel oral partial adenosine A1 receptor agonist for the treatment of heart failure: safety and tolerability in healthy volunteers pretreated with beta-blocker

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Drug therapy, other

Thumbnail

ESC 365 is supported by

logo Novo Nordisk